Patent Assignment
Reel/Frame 068791/0849
Assignment of Assignor's Interest
Recorded: 2024-06-24
Pages: 48
Assignor
AERIE PHARMACEUTICALS, INC.
Executed: 2024-06-18
Assignee
ALCON INC.
RUE LOUIS-D'AFFRY 6, FRIBOURG, 1701, SWITZERLAND
Covered Properties
(52)
Isoquinoline compounds
Application:
60/698,165 →
Rho Kinase Inhibitors
Application:
60/826,284 →
Dual-Action Inhibitors and Methods of Using Same
Application:
61/174,672 →
Combination Therapy
Application:
61/787,883 →
Implant Applicators and Methods, Systems, and Devices Thereof
Application:
62/129,737 →
Implant Applicators and Methods of Administering Implants
Application:
62/263,396 →
Implant Applicators and Methods of Administering Implants
Application:
62/263,373 →
Intravitreal Drug Delivery Systems for the Treatment of Ocular Conditions
Application:
62/196,269 →
Intravitreal Drug Delivery Systems for the Treatment of Ocular Conditions
Application:
62/277,281 →
Intravitreal Drug Delivery Systems for the Treatment of Ocular Conditions
Application:
62/329,763 →
Intravitreal Drug Delivery Systems for the Treatment of Ocular Conditions
Application:
62/358,372 →
Beta-Amino-Isoquinolinyl Amide Compounds
Application:
62/377,219 →
Ophthalmic Compositions
Application:
62/382,237 →
Implant Applicators
Application:
62/383,129 →
Aryl Cyclopropyl-Amino-Isoquinolinyl Amide Compounds
Application:
62/480,239 →
Aryl Cyclopropyl-Amino-Isoquinolinyl Amide Compounds
Application:
62/643,131 →
Mono-(Acid) Salts of 6-Aminoisoquinolines and Uses Thereof
Application:
62/650,687 →
Isoquinoline-Steroid Conjugates and Uses Thereof
Application:
62/725,941 →
Aryl Cyclopropyl-Amino-Isoquinolinyl Amide Compounds
Application:
62/731,609 →
Aryl Cyclopropyl-Amino-Isoquinolinyl Amide Compounds
Application:
62/738,962 →
Compounds, Compositions and Methods for Treatment of Myopia
Application:
62/800,312 →
Compounds, Compositions and Methods for Treatment of Myopia
Application:
62/801,515 →
Compounds, Compositions and Methods for Treatment of Myopia
Application:
62/819,236 →
Pharmaceutical Compositions for Treating Ocular Diseases or Disorders
Application:
62/814,198 →
Heterobicyclic Carboxamides and Uses Thereof
Application:
62/900,263 →
Pharmaceutical Preparation
Application:
62/994,149 →
Treatments
Application:
63/007,103 →
Stable Isoquinoline-Corticosteroid Conjugates and Uses Thereof
Application:
63/181,862 →
Pharmaceutical Preparation
Application:
63/184,593 →
Novel Azetidinyl Pyrimidines and Uses Thereof
Application:
63/217,607 →
Ophthalmic Pharmaceutical Compositions and Uses Thereof
Application:
63/290,781 →
Pyrazole Compounds and Uses Thereof
Application:
63/253,026 →
Process for the preparation of ROCk inhibitors
Application:
63/298,751 →
Azetidinyl Pyrimidines and Uses Thereof
Application:
63/356,670 →
Ocular Protein Delivery
Application:
62/195,640 →
Ocular Protein Delivery
Application:
62/239,022 →
Ocular Protein Delivery
Application:
62/253,979 →
Ocular Protein Delivery
Application:
62/277,233 →
Ocular Protein Delivery
Application:
62/290,807 →
Ocular Protein Delivery
Application:
62/329,723 →
Ocular Protein Delivery
Application:
62/352,259 →
Amino-Benzoisothiazole and Amino-Benzoisothiadiazole Amide Compounds
Application:
62/643,129 →
Amino-Benzoisothiazole and Amino-Benzoisothiadiazole Amide Compounds
Application:
62/738,940 →
Amino-Benzoisothiazole and Amino-Benzoisothiadiazole Amide Compounds
Application:
62/760,592 →
Thienyl Cyclopropyl-Amino-Isoquinolinyl Amide Compounds
Application:
62/810,783 →
Medical Implant
Application:
63/109,615 →
Medical Implant
Application:
63/241,395 →
Implant Delivery Device
Application:
63/176,056 →
Process for the Preparation of Jak Inhibitors
Application:
63/437,084 →
Compounds and Processes for the Preparation of Jak Inhibitors
Application:
63/501,009 →
N-Substituted C6 Cyclyl Carboxamide Compounds and Uses Thereof
Application:
63/460,422 →
Polymorphs of a JAK1/TYK2 Inhibitor and Uses Thereof
Application:
63/465,091 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 10, 2013
From: DELONG, MITCHELL A.; KOPCZYNSKI, CASEY; STURDIVANT, JILL MARIE; LIN, CHENG-WEN
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 030392/0649 →
Assignment of Assignor's Interest
Oct 15, 2015
From: WILLIAMS, STUART
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 036801/0319 →
Assignment of Assignor's Interest
Oct 15, 2015
From: WILLIAMS, STUART
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 036801/0297 →
Assignment of Assignor's Interest
Oct 15, 2015
From: WILLIAMS, STUART
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 036801/0351 →
Assignment of Assignor's Interest
Oct 21, 2015
From: HUNTER, MICHAEL
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 036846/0776 →
Assignment of Assignor's Interest
Dec 10, 2015
From: WILLIAMS, STUART
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 037262/0644 →
Assignment of Assignor's Interest
Mar 7, 2016
From: NAVRATIL, TOMAS; DELGADO, JESSIE
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 037904/0721 →
Assignment of Assignor's Interest
Mar 7, 2016
From: NAVRATIL, TOMAS; DELGADO, JESSIE
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 037904/0561 →
Assignment of Assignor's Interest
Mar 7, 2016
From: HUNTER, MICHAEL; NAVRATIL, TOMAS; DELGADO, JESSIE
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 037904/0624 →
Assignment of Assignor's Interest
Mar 9, 2016
From: WILLIAMS, STUART
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 037932/0042 →
Assignment of Assignor's Interest
Mar 9, 2016
From: WILLIAMS, STUART
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 037931/0861 →
Assignment of Assignor's Interest
Mar 9, 2016
From: WILLIAMS, STUART
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 037932/0029 →
Assignment of Assignor's Interest
Jun 8, 2016
From: WILLIAMS, STUART
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 038845/0794 →
Assignment of Assignor's Interest
Jun 15, 2016
From: WILLIAMS, STUART
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 038920/0763 →
Assignment of Assignor's Interest
Jul 15, 2016
From: WILLIAMS, STUART
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 039169/0053 →
Assignment of Assignor's Interest
Jul 15, 2016
From: WILLIAMS, STUART
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 039169/0069 →
Assignment of Assignor's Interest
Dec 15, 2016
From: NAVRATIL, TOMAS; NADKARNI, AKSHAY NITISH; WILLARD, GRETCHEN; CORSON, ANDREW
To: ENVISIA THERAPEUTICS, INC.
Reel/Frame 040980/0338 →
Assignment of Assignor's Interest
Mar 27, 2017
From: AERIE PHARMACEUTICALS, INC.
To: AERIE DISTRIBUTION, INC.
Reel/Frame 041754/0369 →
Assignment of Assignor's Interest
Mar 27, 2017
From: AERIE DISTRIBUTION, INC.
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 041754/0402 →
Assignment of Assignor's Interest
Apr 13, 2017
From: DELONG, MITCHELL A.; STURDIVANT, JILL M.; LICHOROWIC, CYNTHIA L.
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 042001/0751 →
Assignment of Assignor's Interest
May 31, 2017
From: LIN, CHENG-WEN; KOPCZYNSKI, CASEY; DELONG, MITCHELL A.; STURDIVANT, JILL M.
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 042543/0369 →
Assignment of Assignor's Interest
Oct 20, 2017
From: ENVISIA THERAPEUTICS INC.
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 043911/0952 →
Assignment of Assignor's Interest
Mar 30, 2018
From: DELONG, MITCHELL A.; STURDIVANT, JILL M.; LICHOROWIC, CYNTHIA L.; KORNILOV, ANDRIY
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 045395/0073 →
Security Interest
Jun 13, 2018
From: AERIE PHARMACEUTICALS, INC.
To: DEERFIELD PARTNERS, L.P.; DEERFIELD PRIVATE DESIGN FUND III, L.P.; DEERFIELD INTERNATIONAL MASTER FUND, L.P.; DEERFIELD SPECIAL SITUATIONS FUND, L.P.
Reel/Frame 046079/0551 →
Release of Security Interest
Jul 23, 2018
From: DEERFIELD PARTNERS, L.P.; DEERFIELD PRIVATE DESIGN FUND III, L.P.; DEERFIELD SPECIAL SITUATIONS FUND, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.
To: AERIE PHARMACEUTICALS, INC.
Reel/Frame 046431/0344 →